Ahead of the 7th Annual IMPACCT: Real World Evidence, Sandy Leonard, former VP, Medical Evidence & Observational Research at AstraZeneca has taken some time
Returning for its 7th year, IMPACCT: Real World Evidence provides top innovators and leaders in the real world evidence space with a comprehensive industry forum dedicated to suppo
NICE is to review how it develops guidance on drugs, focusing on issues such as modifiers used in decision making and dealing with uncertainties in evidence.
New rare disease treatments face a complex market access landscape that presents fundamental challenges for pharmaceutical companies seeking to achieve launch excellence.
